Rapamycin extends life span of Rb1+/− mice by inhibiting neuroendocrine tumors
Carolina B. Livi(The University of Texas at San Antonio Health Science Center), Z. Dave Sharp(Mays Cancer Center at UT Health San Antonio), Randy Strong(The University of Texas at San Antonio Health Science Center), Paul Hasty(The University of Texas at San Antonio Health Science Center), Martin A. Javors(The University of Texas at San Antonio Health Science Center), Sherry G. Dodds(The University of Texas at San Antonio Health Science Center), Yuji Ikeno(The University of Texas at San Antonio Health Science Center), Rulon L. Hardman(The University of Texas at San Antonio Health Science Center), Gene B. Hubbard(The University of Texas at San Antonio Health Science Center), D.R. Jones(The University of Texas at San Antonio Health Science Center), Alex Bokov(The University of Texas at San Antonio Health Science Center), Charnae Williams(The University of Texas at San Antonio Health Science Center), Barbara A. Christy(The University of Texas at San Antonio Health Science Center)
Cited by 88
Related Papers
Life-long reduction in MnSOD activity results in increased DNA damage and higher incidence of cancer but does not accelerate aging
|Physiological Genomics|2003|733
Rapamycin‐mediated lifespan increase in mice is dose and sex dependent and metabolically distinct from dietary restriction
|Aging Cell|2013|629
The role of oxidative damage and stress in aging
|Mechanisms of Ageing and Development|2004|621
Is the oxidative stress theory of aging dead?
|Biochimica et Biophysica Acta (BBA) - General Subjects|2009|602
Aging and Genome Maintenance: Lessons from the Mouse?
|Science|2003|548